Prairie Operating Faces NearTerm Headwinds but Bullish Thesis Remains Intact US AI Stocks Plunge as Chinas DeepSeek Sparks Market Selloff Shrinking Oil Inventories Fuel Concerns Over Extended Energy Supply Crunch Samsungs Latest Labor Deal May Set Precedent for Bonus Negotiations Across South Korean Industries Kaynes Technology Among Four Nifty500 Stocks Showing Bullish White Marubozu Pattern Chinas Robot Workforce Ambitions Elon Musk Identifies Key Rival in Humanoid Race FITBI Q1 2026 Earnings Depositary Shares Deliver 35 EPS Surprise Amid Flat Stock Reaction Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending CCM Q2 2016 Earnings Significant EPS Miss Amid Operational Challenges AIT Q1 2026 Earnings EPS Misses Estimates by a Slim Margin Stock Edges Higher ATS Q1 2026 Earnings EPS Surpasses Estimates by 924 Stock Rises 391 GFR Q1 2026 Earnings Negative EPS Disclosed Amid Limited Data Stock Rises 118 NewcelX Ltd NCEL Gains Ground Testing Key Resistance Levels 51Talk COE Dips 22 as Stock Hovers Near Support Level cbdMD Inc YCBD Slips 2 as Stock Tests Key Support Near 070 HAVAR Rights Edge Higher as 011 Support Holds First Capital Inc FCAP Edges Higher Resilience Near Key Resistance Levels Michael Saylor Tokenization May Enable Investors to Shop for Yield Challenging Traditional Banking ELAN Q1 2026 Earnings EPS Surprise Drives Positive Reaction WORK Medical Technology Group WOK Slides 54 as Stock Tests Key 010 Support Level Upexi Inc UPXI Sheds 43 as Shares Approach Crucial Support Zone Estrella Immunopharma ESLA Gains 265 as Shares Find NearTerm Support at 11 DENTSPLY SIRONa XRAY Rallies 28 Testing Key Resistance After Prolonged Decline POSCO Holdings PKX Rises Amid Steel Sector Momentum Key Levels to Watch Kiora Pharmaceuticals KPRX Holds Steady Near Support as Biotech Sector Faces Headwinds Bold Eagle Acquisition Corp BEAG Holds Steady Near Support A Quiet Moment for a Special Purpose Acquisition Vehicle Radiopharm Theranostics RADX Holds Steady at 449 Consolidation Phase for Radiopharma Play